CHRONIC URTICARIA
DOI:
https://doi.org/10.52340/jecm.2025.02.24Keywords:
urticaria, chronic, allergologyAbstract
Chronic spontaneous urticaria is one of the serious challenges of modern clinical allergology, which causes serious decrease and discomfort of patients' quality of life. A separate problem is the difficulties of its management and the low effectiveness of traditional antihistamine drugs (symptomatic treatment). Because of all this, the agenda was on the development of chronic spontaneous urticaria pathogenesis and developing innovative methods in this regard. Serving the article below to discuss this problem.
Downloads
References
P. Kolkhir, F. André, M. K. Church, M. Maurer, and M. Metz, “Potential blood biomarkers in chronic spontaneous urticaria,” Clinical and Experimental Allergy, vol. 47, no. 1, pp. 19–36, 2017.
O. Schmetzer, E. Lakin, F. et al., IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology, vol. 142, no. 3, pp. 876–882, 2018.
Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114:583.
Mari A. Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol 2004; 133:29.
Guttman-Yassky E, Bergman R et al. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol 2007; 21:35.
Taskapan O, Kutlu A, Karabudak O. Evaluation of autologous serum skin test results in patients with chronic idiopathic urticaria, allergic/non-allergic asthma or rhinitis and healthy people. Clin Exp Dermatol 2008; 33:754.
Church, M., Kolkhir, P. et al. The role and relevance of mast cells in urticaria. Immunol. Rev. 282, 232–247 (2018).
Kolkhir, P., Elieh-Ali-Komi, D., Metz, M., Siebenhaar, F. & Maurer, M. Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat. Rev. Immunol. 22, 294–308 (2022).
Yanase, Y., Takahagi, S., Ozawa, K. & Hide, M. The role of coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous urticaria. Cells 10, 1759 (2021).
Okayama, Y. & Kawakami, T. Development, migration, and survival of mast cells. Immunol. Res. 34, 97–115 (2006).
Gilfillan, A., Tkaczyk, C. Integrated signaling pathways for mast-cell activation. Nat. Rev. Immunol.6,218-30 (2006).
Mendes-Bastos, P. et al. Bruton’s tyrosine kinase inhibition — an emerging therapeutic strategy in immune-mediated dermatological conditions. Allergy. 2022.
Schmetzer O, Lakin E, Topal FA, Preusse P, Freier D, Church MK, et al. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 2018;142:876-82.
Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase–a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011;6:e14794.
Asero R, Marzano AV, Ferrucci S, Lorini M, Carbonelli V, Cugno M. Co-occur- rence of IgE and IgG autoantibodies in patients with chronic spontaneous urti- caria. Clin Exp Immunol 2020;200:242-9.
Bar-Sela S, Reshef T, Mekori YA. IgE antithyroid microsomal antibodies in a patient with chronic urticaria. J Allergy Clin Immunol 1999;103:1216-7.
Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol 2017;139:1772-17781.e1.
Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011;128:202-9.e5.
Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria–a clinical, immunological and histologi- cal evaluation. Br J Dermatol 1986;114:583-90.
Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205–217. doi:10.1038/nri2273
Zuberbier, T.; Abdul Latiff, A.H.; Abuzakouk, M.; Aquilina, S.; Asero, R.; Baker, D.; Ballmer-Weber, B et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy Eur. J. Allergy Clin. Immunol. 2022, 77, 734–766.
ბიძინა კულუმბეგოვი - ქრონიკული სპონტანური ურტიკარიის პერსონალიზებური მართვა ანთებითი ბიომარკერებისა და ანტი-IgE მონოკლონური ანტისხეულების გამოყენებით. სადისერტაციო ნაშრომი, თბილისი, 2024
ზაზა თელია - სტრესის, დეპრესიის, შფოთვის, ძილის დარღვევებისა და კანის ალერგიული დაავადებების ურთიერთგავლენა მოზრდილი ასაკის პირებში (რეტროსპექტული საცდელ-საკონტროლო კვლევა), სადისერტაციო ნაშრომი, თბილისი, 2023
Downloads
Published
How to Cite
Issue
Section
